Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$798M |
| 2 |
AT&T
T
|
+$527M |
| 3 |
Microchip Technology
MCHP
|
+$472M |
| 4 |
Netflix
NFLX
|
+$446M |
| 5 |
PNC Financial Services
PNC
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$694M |
| 2 |
KeyCorp
KEY
|
+$401M |
| 3 |
Deere & Co
DE
|
+$322M |
| 4 |
CSX Corp
CSX
|
+$318M |
| 5 |
NXP Semiconductors
NXPI
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.93% |
| 2 | Technology | 4.66% |
| 3 | Healthcare | 4.45% |
| 4 | Industrials | 4.14% |
| 5 | Consumer Discretionary | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5451
CALL
Upbound Group
UPBD
$1.14B
| $967K | ﹤0.01% |
67,200
-44,400
| -40% | -$653K |
|
|
VRAY
5452
DELISTED
ViewRay, Inc.
VRAY
| $967K | ﹤0.01% |
103,360
+81,172
| +366% | +$798K |
|
|
ZVO
5453
DELISTED
Zovio Inc. Common Stock
ZVO
| $967K | ﹤0.01% |
95,182
-8,181
| -8% | -$86.3K |
|
5454
PUT
Boot Barn
BOOT
$4.95B
| $966K | ﹤0.01% |
34,000
+18,400
| +118% | +$486K |
|
5455
CALL
Community Health Systems
CYH
$423M
| $966K | ﹤0.01% |
279,100
+170,900
| +158% | +$556K |
|
5456
CALL
East-West Bancorp
EWBC
$18.7B
| $966K | ﹤0.01% |
16,000
+3,400
| +27% | +$218K |
|
5457
CALL
Xylem
XYL
$27.9B
| $966K | ﹤0.01% |
12,100
-20,900
| -63% | -$1.56M |
|
5458
PUT
ProShares UltraShort Dow 30
DXD
$42.7M
| $965K | ﹤0.01% |
6,720
+960
| +17% | +$148K |
|
|
TVRD
5459
Tvardi Therapeutics
TVRD
$25.3M
| $965K | ﹤0.01% |
1,120
-1,035
| -48% | -$747K |
|
5460
Atlantic Union Bankshares
AUB
$6.12B
| $964K | ﹤0.01% |
+25,028
| New | +$1.02M |
|
5461
CALL
MGP Ingredients
MGPI
$379M
| $964K | ﹤0.01% |
12,200
+1,600
| +15% | +$130K |
|
|
EPZM
5462
DELISTED
Epizyme, Inc
EPZM
| $964K | ﹤0.01% |
90,977
-719,142
| -89% | -$8.21M |
|
5463
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20.3B
| $963K | ﹤0.01% |
+6,759
| New | +$947K |
|
|
FSCT
5464
PUT
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $963K | ﹤0.01% |
+25,500
| New | +$924K |
|
|
FOLD
5465
PUT
DELISTED
Amicus Therapeutics
FOLD
| $962K | ﹤0.01% |
79,600
+28,400
| +55% | +$397K |
|
5466
CALL
iShares National Muni Bond ETF
MUB
$45.8B
| $961K | ﹤0.01% |
8,900
+800
| +10% | +$87K |
|
|
IPHI
5467
CALL
DELISTED
INPHI CORPORATION
IPHI
| $961K | ﹤0.01% |
25,300
-5,800
| -19% | -$200K |
|
5468
iShares Global Equity Factor ETF
GLOF
$224M
| $960K | ﹤0.01% |
+31,220
| New | +$953K |
|
5469
Saic
SAIC
$5.36B
| $959K | ﹤0.01% |
11,895
-22,506
| -65% | -$1.91M |
|
|
LKSD
5470
DELISTED
LSC Communications, Inc.
LKSD
| $959K | ﹤0.01% |
86,701
+1,566
| +2% | +$20.2K |
|
5471
Clearway Energy Class C
CWEN
$7.01B
| $958K | ﹤0.01% |
49,772
+36,525
| +276% | +$697K |
|
5472
First Trust Nasdaq Semiconductor ETF
FTXL
$1.38B
| $958K | ﹤0.01% |
31,441
+9,568
| +44% | +$308K |
|
5473
PUT
Ingevity
NGVT
$2.64B
| $958K | ﹤0.01% |
9,400
+4,400
| +88% | +$425K |
|
5474
PUT
Ormat Technologies
ORA
$7.06B
| $958K | ﹤0.01% |
17,700
+13,200
| +293% | +$700K |
|
5475
Clean Energy Fuels
CLNE
$403M
| $957K | ﹤0.01% |
368,141
-271,270
| -42% | -$755K |
|
Similar funds
Citadel Advisors's Q3 2018 Portfolio in Review
As of Q3 2018, Citadel Advisors held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citadel Advisors deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.
- Citadel Advisors's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
- Citadel Advisors added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
- Citadel Advisors's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
- Citadel Advisors fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
- Citadel Advisors's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
- Citadel Advisors opened 1,427 new positions and closed 1,043 in Q3 2018.
- Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $224B.
Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.